Friedenthal Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Hold
1,261
0.15% 100
2026
Q1
$274K Hold
1,261
0.14% 99
2025
Q4
$288K Sell
1,261
-81
-6% -$18.5K 0.15% 102
2025
Q3
$311K Buy
1,342
+41
+3% +$8.35K 0.16% 97
2025
Q2
$241K Buy
1,301
+1,261
+3,153% +$234K 0.13% 102
2025
Q1
$8.38K Hold
40
0.01% 179
2024
Q4
$7.11K Hold
40
﹤0.01% 212
2024
Q3
$7.9K Hold
40
﹤0.01% 199
2024
Q2
$6.86K Hold
40
﹤0.01% 201
2024
Q1
$7.28K Hold
40
﹤0.01% 197
2023
Q4
$6.2K Buy
+40
New +$5.83K ﹤0.01% 206

Other funds holding ABBV

Friedenthal Financial's ABBV Position: Q2 2026 in Review

Friedenthal Financial held its AbbVie (ABBV) position steady in Q2 2026 at 1,261 shares worth $317K. The position accounts for 0.15% of the portfolio, ranked #100.

Friedenthal Financial first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 962 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Friedenthal Financial held 1,261 shares of AbbVie worth $317K as of Q2 2026.
  • Friedenthal Financial left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.15% of Friedenthal Financial's portfolio in Q2 2026, its #100 holding.
  • Friedenthal Financial first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 962 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Friedenthal Financial's 13F filing for Q2 2026, filed 13 Jul 2026.